UEU-co logo

MD Consult: Books: Goldman: Cecil Medicine: SUGGESTED READINGS

Goldman: Cecil Medicine, 23rd ed.

Copyright © 2007 Saunders, An Imprint of Elsevier

SUGGESTED READINGS

Black D, Greenspan S, Ensrud K, et al: The effects of PTH and alendronate alone or in combination in post-menopausal osteoporosis.  N Engl J Med  2003; 349:1207-1215.The combination of PTH and alendronate is not better than PTH alone

Bischoff-Ferrari HA, Dawson-Hughes B, Willett WC, et al: Effect of vitamin D on falls: A meta-analysis.  JAMA  2004; 291:1999-2006.The best summary of evidence to date on the nonskeletal effects of vitamin D

Bone HG, Hosking D, Devogelaer JP, et al: Ten years’ experiences with alendronate for osteoporosis in postmenopausal women.  N Engl J Med  2004; 350:1189-1199.The longest study to date examining the effects of alendronate on the skeleton

Center JR, Bliuc D, Nguyen TV, et al: Risk of subsequent fracture after low-trauma fracture in men and women.  JAMA  2007; 297:387-394.Increase in risk of subsequent fracture persisted for 10 years

Finkelstein JS, Hayes A, Hunzelman JL, et al: The effects of parathyroid hormone, alendronate, or both in men with osteoporosis.  N Engl J Med  2003; 349:1216-1226.

Odvina CV, Zerwekh JE, Rao DS, et al: Severely suppressed bone turnover: A potential complication of alendronate therapy.  J Clin Endocrinol Metab  2005; 90:1294-1301.One of the most controversial articles in the bone literature; an anecdotal review of nine cases suggesting impaired fracture healing and very low bone turnover in patients receiving long-term alendronate therapy. The difficulty is the small numbers of subjects and the huge implications, which have not been borne out from clinical trials

Riggs BL, Hartmann LC: Selective estrogen-receptor modulators: Mechanisms of action and application to clinical practice.  N Engl J Med  2003; 348:618-629.An outstanding and up-to-date review of the molecular, cellular, and skeletal actions of the selective estrogen receptor modulators

Sambrook P, Cooper C: Osteoporosis.  Lancet  2006; 367:2010-2018.A comprehensive overview

Siris ES, Harris ST, Rosen CJ, et al: Adherence to bisphosphonate therapy and fracture rates in osteoporotic women: Relationship to vertebral and nonvertebral fractures from 2 US claims databeses.  Mayo Clin Proc  2006; 81:1013-1022.Increasing refill compliance was associated with a reduced risk of fracture

Surgeon General Bone Health and Osteoporosis: A Report of the Surgeon General,  Rockville, MD: U.S. Department of Health and Human Services; 2004:436.A comprehensive evaluation of the implications of osteoporosis on society and includes diagnosis, treatment, and prevention recommendations as well as newer public health initiatives

Uitterlinden AG, Ralston SH, Brandi ML, et al: The association between common vitamin D receptor gene variations and osteoporosis: A participant-level meta-analysis.  Ann Intern Med  2006; 145:255-264.The cdx2 polymorphism was associated with a reduced fracture risk

Email to Colleague Print Version

Copyright © 2007 Elsevier Inc. All rights reserved. –

Leave a Reply


Time limit is exhausted. Please reload the CAPTCHA.

Categories

apply_now Pepperstone Group Limited